PMS30 - COST ANALYSIS FOR DIFFERENT ANTI-RHEUMATOID BIOLOGICAL TREATMENTS AFTER FAILURE OF CONVENTIONAL DMARDS IN PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS IN THE KINGDOM OF SAUDI ARABIA

Journal article

Open access

Peer reviewed

Value in health, Vol.21, pp.S292-S292

10/2018

Files and links (1)

url

https://doi.org/10.1016/j.jval.2018.09.1744View

Published (Version of record) Open

1 Record Views

Title: PMS30 - COST ANALYSIS FOR DIFFERENT ANTI-RHEUMATOID BIOLOGICAL TREATMENTS AFTER FAILURE OF CONVENTIONAL DMARDS IN PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS IN THE KINGDOM OF SAUDI ARABIA
Creators - without role: L. Al Jawaheri - King Saud University
H. AL-Mudaiheem - Ministry of Health
M. Khalil - Ministry of Health
H. Mohammed - King Saud University
A. Ibrahim - Accsight, Dubai, United Arab Emirates
I. Anan - Accsight, Cairo, Egypt
M. Omair - King Saud University
Publication Details: Value in health, Vol.21, pp.S292-S292
Publisher: Elsevier Inc
Identifiers: 9951962808331
Academic Unit: King Saud University
Language: English
Resource Type: Journal article